Steve Engen Location
- Bellevue, WA, US
Steve Engen Work
- 2019 -now Chief Executive Officer @ Renexes LLC
- 2026 -now Board Member @
- 2026 -now Business Development Advisor @
- 2025 -now Advisor @
- 2024 -now Board Member @
- 2024 -now Advisor @ Breakthrough T1D Fund
- 2023 -now Japan Advisor @
- 2018 -now Strategic Partner @
- 2014 -now Japan Asia Advisor @
- 2025 -now Advisor @
- 2023 -2026 Advisor @
- 2024 -2025 Advisor @
- 2024 -2025 Advisor @
- 2022 -2024 Advisor @
- 2023 -2024 Advisor @
- 2022 -2024 Advisor @ LIB Therapeutics
- 2023 -2024 Advisor @
- 2022 -2024 Advisor @
- 2023 -2023 Advisor @ Cerevel Therapeutics
- 2022 -2023 Advisor @
- 2021 -2023 Advisor @
- 2021 -2023 Advisor @
- 2022 -2023 Advisor @
- 2022 -2023 Advisor @ Landos Biopharma, Inc.
- 2021 -2023 Board Member @ Laevoroc
- 2022 -2022 Advisor @ EQRx
- 2022 -2022 Advisor @
- 2022 -2022 Advisor @
- 2020 -2021 Director Of Business Development @
- 2018 -2021 Member of the Board of Directors (Independent Director) @ TMS Co., Ltd.
- 2014 -2019 CEO @ Renegen KK
- 2014 -2018 Managing Director @
- 2014 -2018 Managing Director Asia @
- 2015 -2015 Advisor @ Nichiiko Pharmaceutical Co., Ltd.
- 2013 -2014 Vice President and Representative Director, Shire Japan @ Shire Pharmaceuticals
- 2007 -2013 President and CEO @ Solasia Pharma K.K.
- 1998 -2007 President and Representative Director, Mundipharma Japan @
- 1993 -1998 Senior Manager, Licensing @
- now Product Development @ Ezaki Glico Co. Ltd.
- now Manager @ SoundOff Records
Steve Engen Education
- Temple University
MBA (Business & Finance)
1998-2000 - University of Utah
BS (Economics, French, Russian, Japanese)
1985-1990
Steve Engen Skills
- Japanese
- Marketing Strategy
- Pharmaceuticals
- Biotechnology
- Beginning Chinese
- Company Building
- Clinical Development
- Pharmaceutical Industry
- Lifesciences
- Competitive Analysis
- Drug Development
- Product Launch
- Clinical Trials
- Management
- Mergers & Acquisitions
- Medical Devices
- Regulatory Affairs
- Regulatory Submissions
- Negotiation
- Oncology
- Biopharmaceuticals
- Cross-functional Team Leadership
- Product Development
- Drug Discovery
- Pharmaceutics
- Marketing
- Technology Transfer
- Market Research
- Market Analysis
- Strategy
- Start-ups
- Infectious Diseases
- Business Development
- Clinical Research
- Licensing
- CRO
- Market Access
- Chinese
- Commercialization
- Global Marketing
- Start Ups
- Cross Functional Team Leadership
- Mergers and Acquisitions
- Neurology
- Life Sciences
Steve Engen Summary
- Steve Engen, based in Bellevue, WA, US, is currently a Chief Executive Officer at Renexes LLC. Steve Engen brings experience from previous roles at CMIC Group, Tanabe Pharma, Aspect Biosystems and SFG SCIENCES. Steve Engen holds a 1998 - 2000 MBA in Business & Finance @ Temple University. With a robust skill set that includes Japanese, Marketing Strategy, Pharmaceuticals, Biotechnology, Beginning Chinese and more. Steve Engen has 6 emails on RocketReach.
5 free lookup(s).
If you need more lookups,
subscriptions start at $34 USD/month.
Looking for a different Steve Engen?
Find contact details for 700 million professionals.
Others Named Steve Engen
Steve Engen
Chief Executive Officer
Bellevue, WA, US
Steve Engen
mortgage banker
Phoenix, AZ, US
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co